Clinical Characteristics of Patients with Staphylococcus aureus Bile Infection.


Journal

The Israel Medical Association journal : IMAJ
ISSN: 1565-1088
Titre abrégé: Isr Med Assoc J
Pays: Israel
ID NLM: 100930740

Informations de publication

Date de publication:
Oct 2022
Historique:
entrez: 30 10 2022
pubmed: 31 10 2022
medline: 2 11 2022
Statut: ppublish

Résumé

The hepatobiliary system is a sterile micro-environment. Bacterial infection in this system is most commonly associated with anaerobes as well as gram-positive and gram-negative bacteria. Biliary infections with Staphylococcus aureus are poorly characterized. To depict the clinical characteristics and outcome of patients with S. aureus infection of the hepatobiliary system. Medical records of patients with bile cultures positive for S. aureus from January 2006 to November 2020 were extracted from the computerized database of a hospital in Israel. We analyzed the results of 28 cases that were found in the database. The mean age of study patients was 62.2 ± 19 years. Hypertension, dyslipidemia, chronic kidney disease, diabetes, and benign prostatic hypertrophy were the most common co-morbidities (57.1%, 32.1%, 25%, 25%, and 25%, respectively). Fourteen of the methicillin-resistant S. aureus (MRSA) bile cultures (82.3%) were a result of primary S. aureus biliary infections (no other source for S. aureus infection) and the remainder were of a secondary infection. Eight of the MRSA cultures (47.1%) were from hospital acquired infections. Increased hospital mortality in patients with S. aureus hepatobiliary infection was associated with hypertension (P = 0.04), bedridden status (P = 0.01), and nursing home residence (P = 0.003). Hepatobiliary infection with S. aureus can manifest in a variety of ways. S. aureus should be especially considered in patients who are bedridden, present with hypertension, or live in nursing homes because of their association with in-hospital mortality resulting from this entity.

Sections du résumé

BACKGROUND BACKGROUND
The hepatobiliary system is a sterile micro-environment. Bacterial infection in this system is most commonly associated with anaerobes as well as gram-positive and gram-negative bacteria. Biliary infections with Staphylococcus aureus are poorly characterized.
OBJECTIVES OBJECTIVE
To depict the clinical characteristics and outcome of patients with S. aureus infection of the hepatobiliary system.
METHODS METHODS
Medical records of patients with bile cultures positive for S. aureus from January 2006 to November 2020 were extracted from the computerized database of a hospital in Israel.
RESULTS RESULTS
We analyzed the results of 28 cases that were found in the database. The mean age of study patients was 62.2 ± 19 years. Hypertension, dyslipidemia, chronic kidney disease, diabetes, and benign prostatic hypertrophy were the most common co-morbidities (57.1%, 32.1%, 25%, 25%, and 25%, respectively). Fourteen of the methicillin-resistant S. aureus (MRSA) bile cultures (82.3%) were a result of primary S. aureus biliary infections (no other source for S. aureus infection) and the remainder were of a secondary infection. Eight of the MRSA cultures (47.1%) were from hospital acquired infections. Increased hospital mortality in patients with S. aureus hepatobiliary infection was associated with hypertension (P = 0.04), bedridden status (P = 0.01), and nursing home residence (P = 0.003).
CONCLUSIONS CONCLUSIONS
Hepatobiliary infection with S. aureus can manifest in a variety of ways. S. aureus should be especially considered in patients who are bedridden, present with hypertension, or live in nursing homes because of their association with in-hospital mortality resulting from this entity.

Identifiants

pubmed: 36309859

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-648

Auteurs

Ron Skorochod (R)

Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel, Internal Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.

David Raveh (D)

Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel, Infectious Disease, Shaare Zedek Medical Center, Jerusalem, Israel.

Yonit Wiener-Well (Y)

Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel, Infectious Disease, Shaare Zedek Medical Center, Jerusalem, Israel.

Bashar Fteiha (B)

Gastroenterology and Liver Diseases, Shaare Zedek Medical Center, Jerusalem, Israel.

Shimon Shteingart (S)

Department of Nursing, Jerusalem College of Technology, Jerusalem, Israel.

Yitzhak Skorochod (Y)

Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel, Internal Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH